Viewing Study NCT00000751


Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2026-05-27 @ 10:12 PM
Study NCT ID: NCT00000751
Status: COMPLETED
Last Update Posted: 2008-09-30
First Post: 1999-11-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
Sponsor:
Organization: